Operating Lease, Right-of-Use Asset of CATALYST PHARMACEUTICALS, INC. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CATALYST PHARMACEUTICALS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • CATALYST PHARMACEUTICALS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $1,935,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CATALYST PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,935,000 -$295,000 -13% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $2,010,000 -$291,000 -13% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $2,084,000 -$287,000 -12% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $2,158,000 -$282,000 -12% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $2,230,000 -$278,000 -11% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $2,301,000 -$274,000 -11% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $2,371,000 -$270,000 -10% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $2,440,000 -$266,000 -9.8% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $2,508,000 -$262,000 -9.5% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $2,575,000 -$258,000 -9.1% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $2,641,000 -$254,000 -8.8% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $2,706,000 -$251,000 -8.5% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $2,770,000 -$247,000 -8.2% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $2,833,000 -$260,000 -8.4% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $2,895,000 -$306,000 -9.6% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $2,957,000 -$352,000 -11% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $3,017,000 +$3,017,000 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $3,093,000 +$3,080,833 +25321% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $3,201,000 +$3,129,289 +4364% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $3,309,000 +$2,578,716 +353% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $0 -$793,252 -100% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 $12,167 -$940,173 -99% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $71,711 -$941,879 -93% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $730,284 -$343,736 -32% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $793,252 +$793,252 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 $952,340 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $1,013,590 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $1,074,020 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.